Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Lodoxamide

A mast cell stabiliser in eye-drop form, approved in the United States in 1993 for vernal keratoconjunctivitis, an intense form of eye allergy that mainly affects children and young people. This family brings together the active ingredient and other impurities.

Did you know?It is not an antihistamine: it acts earlier, stopping mast cells from releasing histamine. It is thought to block the entry of calcium into these cells when they meet the allergen.

LodoxamideGo to the active ingredient →
LodoxamideActive ingredientLodoxamideCat. No. P-L081-001CAS 53882-12-5
OxamideImpurityOxamideCat. No. P-L081-018CAS 471-46-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.